IHS Chemical Week

Regions :: North America :: U.S.

NPIL and Napo Codevelop Drug

10:53 AM MDT | July 27, 2007 | Chemical Week Editorial Staff

Napo Pharmaceuticals (San Francisco) and Nicholas Piramal India Ltd. (NPIL; Mumbai) say they have entered into a plant-screening agreement to discover novel therapeutic compounds for treating diabetes. NPIL will use its screening facility and natural product chemistry expertize, along with its biological testing capabilities, to identify active compounds from Napo’s library of medicinal plant extracts from tropical regions. Napo and NPIL will jointly own all products that are developed under the agreement. “This agreement allows us to use our advanced...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa